No Causal Link Between Stimulants and Psychotic Experiences in Kids With ADHD
Key Takeaways: There was no evidence to support a causal relationship between stimulant prescription and psychotic experiences in children, ages 9-14 years, treated for attention deficit-hyperactivity disorder. In unweighted analyses, stimulant prescription was associated with subsequent psychotic experiences; however, the reverse was also true in that baseline psychotic experiences predicted subsequent stimulant treatment. When applying…
Read MoreShould I Tell My Boss I Have ADHD?
Key points: The disclosure dilemma means wrestling with whether or not to hide a maskable stigmatized identity. Disclosure isn’t all or nothing—there’s a wide continuum of ways to share. A decisional matrix is one tool that can bring clarity. Those struggling with whether to disclose are not alone—millions are navigating this same decision.
Read MoreMedicaid Unwinding Linked to Disrupted Chronic Medication Therapy in Youth
Key Takeaways: Medicaid unwinding led to significant disruptions in chronic medication therapy for young adults, particularly in states with high enrollment losses. The study utilized a difference-in-differences analysis of the IQVIA Longitudinal Prescription Database to assess prescription continuity. States with higher Medicaid enrollment losses saw greater reductions in active prescriptions and increased cash-pay prescriptions. The…
Read MoreThe Impact of Sleep Medications on Psychiatric Disorders
Collaboration in sleep medicine can optimize treatment for conditions like narcolepsy, ADHD, and insomnia.
Read MoreTeens with mental health conditions use social media differently than their peers, study suggests
Summary: One of the first studies in this area to use clinical-level diagnoses reveals a range of differences between young people with and without mental health conditions when it comes to social media — from changes in mood to time spent on sites.
Read MoreRace and ethnicity often not reported in trials of medications for mental health conditions
A new study led by the University of Southampton has found that the race and ethnicity of participants in clinical trials of medications for mental health and neurodevelopmental conditions often go unrecorded. In the first comprehensive quantitative review of its kind, an international team of researchers found that just four in ten clinical trials (39%)…
Read MorePathological Demand Avoidance 101 | Undivided Conversations
In this conversation, we dive into Pathological Demand Avoidance (PDA)—what it really means, why it’s often misunderstood, and how we can better support kids and adults who experience it. Joining us are Diane Gould, LCSW, founder and executive director of PDA North America; Jessica Richards, MS, MSW, LCSW, licensed psychotherapist; Molly Williams, M.S.W., A.C.S.W., a…
Read MoreThe New York Times Moves the Goalposts on ADHD (Commentary)
This critical analysis of recent ADHD coverage challenges misconceptions about treatment, emphasizing the need for a comprehensive approach to mental health.
Read More‘Dangerous nonsense’: AI-authored books about ADHD for sale on Amazon
Experts say online retailer has ethical responsibility to guard against chatbot-generated work on sensitive topics
Read MoreMisinformation leading to self-diagnosing ADHD
A new study finds that many adults are self-diagnosing themselves with ADHD, in large part due to the wealth of information and misinformation on social media sites like TikTok. Dr. Mallika is on call to discuss the actual signs and symptoms of ADHD.
Read MoreADHD in formerly institutionalized children tied to slower physical and brain growth
A new study published in the Journal of Child Psychology and Psychiatry provides insight into how early-life institutional care affects physical and brain development—and how these developmental patterns are linked to attention-deficit/hyperactivity disorder (ADHD). Children who were raised in institutions before being placed in foster care showed delayed physical growth and changes in brain activity,…
Read MoreHow Genes Influence the Timing of a Baby’s First Step
Key points: Children vary in when they start walking unaided, it can be anytime from age 8 months to 24 months. The genes that influence this walking milestone are expressed in the brain and influence its structure. We discovered that the genes influencing walking also affect later outcomes such as ADHD.
Read More